Navigation Links
Research Team Clones Genes Responsible for Amino Acid Absorption
Date:5/23/2008

MORGANTOWN, W.Va., May 23 /PRNewswire-USNewswire/ -- Researchers at the West Virginia University School of Medicine have discovered ways to block substances that interfere with absorption of nutrients in patients with inflammatory bowel disease (IBD), according to Uma Sundaram, M.D., Section Chief of Digestive Diseases at WVU.

"The most important step before development of drugs that could replace steroids in treating this chronic condition is to find out the specific bodily immune substance that causes the problem. This is the focus of our research," Dr. Sundaram said. "Our lab has shown for the first time not only how an important building block of proteins, glutamine, is absorbed, but also we have cloned a gene responsible for this absorption. And most important, we have shown how the absorption of this important nutrient is affected in IBD."

Details of these discoveries are included in one of nine presentations by Sundaram's research team at the Digestive Disease Week (DDW) conference in San Diego, Calif. The DDW conference began May 17 and continued through May 22. It's described as the world's largest gathering of its type involving physicians and researchers.

The most common chronic disease affecting the human small intestine, IBD affects more than a million people in this country and many more millions around the world.

"In the majority of cases of inflammatory bowel disease, patients are unable to properly assimilate chemicals, water and nutrients that are critical for daily life," Sundaram said.

Sundaram described the WVU lab's breakthroughs as akin to looking for a needle in a haystack in identifying which mediators interfere with what substance the body needs to absorb.

"We have found the needle for a few of the big ones such as how fat, glucose, salt and glutamine absorption is affected," he said. "The next step would be to find specific treatments for inflammatory bowel disease that avoid all the complications of steroids and other drugs currently available."

Sundaram said these discoveries may have equally important implications for conditions such as obesity, which is a serious health concern in West Virginia.

The digestive disease research is funded with National Institutes of Health grants totaling almost $5 million over five years. Five of the research team's papers were published earlier this year in the American Journal of Physiology.

For more information on the WVU Healthcare and digestive diseases, visit http://www.hsc.wvu.edu/som/medicine/digestiveDiseases/.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.


'/>"/>
SOURCE West Virginia University School of Medicine
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Israel , December 5, 2016 ... identifying, in-licensing and developing promising therapeutic candidates, presents positive Phase ... BL-8040, the Company,s leading oncology platform at the ongoing 58th ... San Diego, California . ... , , ...
(Date:12/5/2016)... Taiwan , Dec. 5, 2016 ... non-inferiority to hydroxyurea (HU) in Complete Hematologic Response (CHR) ... profile of ropeginterferon alfa-2b versus HU AOP ... follow-up trial CONTINUATION-PV to obtain European marketing authorization in the ... data to the FDA as it seeks approval for commercialization ...
(Date:12/4/2016)... --  Pairnomix, LLC, a genetic research company and member ... White House, today announced that findings from its first case ... therapies for a patient with epileptic encephalopathy caused by a ... the 70 th Annual Meeting of the American ... December 2-6, 2016.  Pairnomix, unique process involves creating ...
Breaking Medicine Technology:
(Date:12/4/2016)... (PRWEB) , ... December 02, 2016 , ... ... will give patients better access to nutraceuticals and help doctors more efficiently manage ... patient portal and practice management software platform for Integrative and Functional Medicine. ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-Aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
(Date:12/4/2016)... ... December 04, 2016 , ... Are You Concerned About Mold ... certified and experienced Indoor Air Quality Companies in VA, MD and DC, recently completed ... , The new mold law in the district of Columbia is a good ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... documentary on the perils of heroin that was watched live by 1 million ... Alfred I. duPont-Columbia University Award. , ASU students at the Walter Cronkite School ...
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
Breaking Medicine News(10 mins):